XELPOVIO
Dead / Abandoned — Abandoned — no statement of use filed (as of 27 Jan 2020)
What this means for you
This application is over — abandoned 27 Jan 2020. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 87756402
- Mark type
- Stylized text
- Filed
- 16 Jan 2018
- Published for opposition
- 01 May 2018
- Abandoned
- 27 Jan 2020
- Attorney of record
- Nicole Kinsley, Esq.
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, drugs for the treatment of cancer, inflammation and other diseases related to cell proliferation in humans and animals
Owner
- Karyopharm Therapeutics Inc., Newton, MA, US
- Karyopharm Therapeutics Inc., Newton, MA, US
Prosecution history
- 27 Jan 2020 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 27 Jan 2020 — ABANDONMENT - NO USE STATEMENT FILED
- 04 Jun 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Jun 2019 — SOU EXTENSION 2 GRANTED
- 01 Jun 2019 — SOU EXTENSION 2 FILED
- 01 Jun 2019 — SOU TEAS EXTENSION RECEIVED
- 18 Oct 2018 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Oct 2018 — SOU EXTENSION 1 GRANTED
- 16 Oct 2018 — SOU EXTENSION 1 FILED
- 16 Oct 2018 — SOU TEAS EXTENSION RECEIVED
- 26 Jun 2018 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 01 May 2018 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 01 May 2018 — PUBLISHED FOR OPPOSITION
- 11 Apr 2018 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 26 Mar 2018 — APPROVED FOR PUB - PRINCIPAL REGISTER